|
UPF3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.721830E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.013970E-01 |
| Normal-vs-Stage2 |
1.446630E-01 |
| Normal-vs-Stage3 |
1.186600E-01 |
| Normal-vs-Stage4 |
1.999650E-02 |
| Stage1-vs-Stage2 |
5.627600E-01 |
| Stage1-vs-Stage3 |
6.239400E-01 |
| Stage1-vs-Stage4 |
1.189620E-01 |
| Stage2-vs-Stage3 |
9.468400E-01 |
| Stage2-vs-Stage4 |
3.668400E-01 |
| Stage3-vs-Stage4 |
2.909600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.820300E-02 |
| Normal-vs-AfricanAmerican |
1.774120E-02 |
| Normal-vs-Asian |
7.774900E-04 |
| Caucasian-vs-AfricanAmerican |
2.093200E-01 |
| Caucasian-vs-Asian |
6.937800E-02 |
| AfricanAmerican-vs-Asian |
1.793760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.524490E-02 |
| Normal-vs-Female |
8.897700E-02 |
| Male-vs-Female |
3.694000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.404200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.738500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.158980E-01 |
| Normal-vs-Age(81-100Yrs) |
7.979200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.069600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.938600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.640200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.503800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.874200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.063000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.17040000000313E-05 |
| Normal-vs-Grade 2 |
1.549930E-02 |
| Normal-vs-Grade 3 |
2.894800E-01 |
| Normal-vs-Grade 4 |
5.073600E-02 |
| Grade 1-vs-Grade 2 |
2.318000E-03 |
| Grade 1-vs-Grade 3 |
4.556300E-04 |
| Grade 1-vs-Grade 4 |
5.748400E-02 |
| Grade 2-vs-Grade 3 |
1.781160E-01 |
| Grade 2-vs-Grade 4 |
4.700200E-01 |
| Grade 3-vs-Grade 4 |
1.676610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.160000E-02 |
| Normal-vs-ccB subtype |
2.679200E-01 |
| ccA subtype-vs-ccB subtype |
3.798800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.309360E-01 |
| Normal-vs-N1 |
3.960800E-01 |
| N0-vs-N1 |
9.807200E-01 |
|
|
